Global Health Ltd
Global Health Q2 FY26 earnings call: Revenue & Margins
Q2 FY26 earnings call: what management guided on revenue, margins and order book.
The short version
Developing hospitals (Lucknow, Patna, Noida) continue strong double-digit growth; revenue up ~30% YoY including Noida. Management is optimistic about future growth, expecting steady ramp-up and improved performance in developing hospitals like Noida, Lucknow, Patna, and Ranchi over the next 12-18 months.
From Global Health Ltd's Q2 FY26 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- Developing hospitals (Lucknow, Patna, Noida) continue strong double-digit growth; revenue up ~30% YoY including Noida.
- Lucknow hospital showing 30% inpatient volume growth, occupancy ~67%, driven by added clinical talent and specialties.
- Ranchi facility expanding with new specialties and Oncology services planned; volumes growing ~15% YoY.
- Noida hospital operational since Sept 2025, early contribution noted; insurance empanelments expected soon to accelerate growth.
- Additional beds opened in Patna and Lucknow; more bed additions planned, supporting volume growth without necessarily requiring new hospitals.
- New projects in Guwahati, Mumbai (Oshiwara), South Delhi, and Pitampura progressing; expected commissioning ~3-4 years out.
2 more points from Global Health Ltd's call on revenue
Pro opens every point from 15K+ earnings calls
Profitability & Margins
See what Global Health Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Guwahati Project: Completed acquisition of 3.5-acre land (~INR 600 million); Bhoomi Pujan done on October 31, 2025; construction commencement underway; expected 3-4 years to complete.
- Mumbai, Oshiwara Project: Received approval for increased FSI, expanding bed capacity from 500 to 750; Board approved new project cost of INR 15,300 million including land, construction, medical equipment, and INR 850 million for staff residential apartments; construction to start soon.
- South Delhi & Pitampura Projects: Digging started in South Delhi; Pitampura plans submitted for approval and construction to commence post-approval; timeline also expected around 3-4 years.
- Ranchi Expansion: Commissioned 110 new beds; plans to add Oncology services and optimize specialty mix.
2 more points from Global Health Ltd's call on capex
Pro opens every point from 15K+ earnings calls
Top-ranked in Healthcare Services
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Global Health Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
2 more points from Global Health Ltd's call on order book
Pro opens every point from 15K+ earnings calls
Global Health Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹1.2K Cr, net profit ₹142 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Global Health Ltd's management said in earlier quarters
- Q1 FY27 earnings call analysis →
- Q4 FY26 earnings call analysis →
- Q3 FY26 earnings call analysis →
- Q1 FY26 earnings call analysis →
- Q4 FY25 earnings call →
- Q2 FY25 earnings call →
- Q1 FY25 earnings call →
- Q4 FY24 earnings call →
- Q3 FY24 earnings call →
- Q2 FY24 earnings call →
- Q1 FY24 earnings call →
- Q4 FY23 earnings call →
Others in Healthcare Services this season
- Maitreya Medica. (Q2 FY26)
23.92 crore (Page 26). Key investor presentation takeaways from Maitreya Medica.'s Q2 FY26 investor presentation — and how it ranks against sector peers.
- Metropolis Healt (Q2 FY26)
Organic growth remains strong at around 12%, with no immediate price hikes planned. Key concall takeaways from Metropolis Healt's Q2 FY26 earnings call — and…
- 3B Blackbio (Q2 FY26)
Q2 FY 2025-26 sales: ₹3042.83 Lakh (including COVID sales ₹10.23 Lakh), up from ₹2457.55 Lakh in Q2 FY 2024-25. Key concall takeaways from 3B Blackbio DX Ltd's…
- Unihealth Hosp (Q2 FY26)
Nashik financial closure achieved via equity and bank debt (INR 22 crores from Bank of India). Key concall takeaways from Unihealth Hospitals Ltd's Q2 FY26…
Arthneeti Pro · Annual
Global Health Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Global Health Ltd Q2 FY26 results?
Developing hospitals (Lucknow, Patna, Noida) continue strong double-digit growth; revenue up ~30% YoY including Noida. Management is optimistic about future growth, expecting steady ramp-up and improved performance in developing hospitals like Noida, Lucknow, Patna, and Ranchi over the next 12-18 months.
What is Global Health Ltd share price analysis?
Global Health Ltd currently shows a neutral. The stock trades at a P/E of 66.2 with a market cap of ₹37,919 Cr. Investors should review the full earnings analysis for detailed insights.
Is Global Health Ltd planning capital expenditure?
Guwahati Project: Completed acquisition of 3.5-acre land (~INR 600 million); Bhoomi Pujan done on October 31, 2025; construction commencement underway; expected 3-4 years to complete.
Keep Global Health Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.